Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Treasury Shares (2017 - 2023)

Nephros has reported Treasury Shares over the past 6 years, most recently at $42167.0 for Q4 2023.

  • Quarterly results put Treasury Shares at $42167.0 for Q4 2023, up 62.68% from a year ago — trailing twelve months through Dec 2023 was $42167.0 (up 62.68% YoY), and the annual figure for FY2023 was $42167.0, up 62.68%.
  • Treasury Shares for Q4 2023 was $42167.0 at Nephros, up from $25920.0 in the prior quarter.
  • Over the last five years, Treasury Shares for NEPH hit a ceiling of $55.1 million in Q4 2019 and a floor of $25920.0 in Q4 2022.
  • Median Treasury Shares over the past 4 years was $50949.5 (2021), compared with a mean of $13.8 million.
  • Biggest five-year swings in Treasury Shares: skyrocketed 110365.02% in 2019 and later crashed 56.61% in 2022.
  • Nephros' Treasury Shares stood at $55.1 million in 2019, then crashed by 99.89% to $59732.0 in 2021, then crashed by 56.61% to $25920.0 in 2022, then skyrocketed by 62.68% to $42167.0 in 2023.
  • The last three reported values for Treasury Shares were $42167.0 (Q4 2023), $25920.0 (Q4 2022), and $59732.0 (Q4 2021) per Business Quant data.